Amicus Therapeutics Inc (FOLD)
10.34
-0.21
(-1.99%)
USD |
NASDAQ |
Apr 18, 16:00
10.34
0.00 (0.00%)
After-Hours: 20:00
Amicus Therapeutics Gross Profit (TTM): 362.03M for Dec. 31, 2023
Gross Profit (TTM) Chart
Historical Gross Profit (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 362.03M |
September 30, 2023 | 336.98M |
June 30, 2023 | 311.68M |
March 31, 2023 | 298.83M |
December 31, 2022 | 290.63M |
September 30, 2022 | 286.22M |
June 30, 2022 | 285.82M |
March 31, 2022 | 282.32M |
December 31, 2021 | 271.05M |
September 30, 2021 | 257.90M |
June 30, 2021 | 249.09M |
March 31, 2021 | 235.73M |
December 31, 2020 | 229.84M |
September 30, 2020 | 217.04M |
June 30, 2020 | 201.17M |
March 31, 2020 | 184.26M |
December 31, 2019 | 160.27M |
September 30, 2019 | 140.23M |
June 30, 2019 | 113.34M |
March 31, 2019 | 92.75M |
December 31, 2018 | 76.84M |
September 30, 2018 | 60.66M |
June 30, 2018 | 53.46M |
March 31, 2018 | 41.38M |
December 31, 2017 | 30.69M |
Date | Value |
---|---|
September 30, 2017 | 20.92M |
June 30, 2017 | 13.62M |
March 31, 2017 | 7.519M |
December 31, 2016 | 4.125M |
September 30, 2016 | 1.783M |
June 30, 2016 | 0.00 |
March 31, 2016 | |
December 31, 2015 | |
September 30, 2015 | |
June 30, 2015 | |
March 31, 2015 | |
December 31, 2014 | |
September 30, 2014 | |
June 30, 2014 | |
March 31, 2014 | |
December 31, 2013 | |
September 30, 2013 | |
June 30, 2013 | |
March 31, 2013 | |
December 31, 2012 | |
September 30, 2012 | |
June 30, 2012 | |
March 31, 2012 | |
December 31, 2011 | |
September 30, 2011 |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (TTM) Range, Past 5 Years
113.34M
Minimum
Jun 2019
362.03M
Maximum
Dec 2023
248.13M
Average
257.90M
Median
Sep 2021
Gross Profit (TTM) Benchmarks
TG Therapeutics Inc | 219.53M |
Geron Corp | -- |
Vanda Pharmaceuticals Inc | 177.84M |
Fate Therapeutics Inc | -- |
Editas Medicine Inc | -- |